Diana Barb

5PUBLICATIONS
21CO-AUTHORS
Te mātai tahumaero o te Māori (Māori epidemiology)Food properties (incl. characteristics and health benefits)Gastroenterology and hepatologyNutrition and dietetics not elsewhere classifiedPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 11, 2026
Severity of MASH activity by iron-corrected MRI predicts insulin resistance and cardiometabolic risk in type 2 diabetes.

Andrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva

|Jul 30, 2025
Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease.

Layla A Abushamat, Pir Ahmad Shah, Robert H Eckel

|Feb 02, 2023
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.

Mary E Rinella, Brent A Neuschwander-Tetri, Mohammad Shadab Siddiqui

|Apr 08, 2022
Response to: "Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?"

Diana Barb, Kenneth Cusi

|Jul 05, 2021
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.

Amalia Gastaldelli, Silvia Sabatini, Fabrizia Carli

Pageof 1